Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Additional Information (Details)

v3.23.1
Stockholders' Equity - Additional Information (Details) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended
Aug. 03, 2022
Aug. 01, 2022
Aug. 13, 2021
May 31, 2022
Jan. 31, 2022
Feb. 28, 2022
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Subsidiary or Equity Method Investee [Line Items]                    
Common stock, shares authorized   70,000,000           70,000,000 30,000,000  
Preferred stock, shares authorized   30,000,000           30,000,000 70,000,000  
Common stock, par value               $ 0.0001 $ 0.0001  
Preferred stock, shares issued               0 0  
Preferred stock, par value               $ 0.0001 $ 0.0001  
Common stock, shares issued               10,955,904 7,584,980  
Number of common stock sold       11,111   263,729        
Sale of common stock, price per share       $ 9   $ 9        
Common stock per share           $ 9.00       $ 8.00
Gross proceeds from sale of common stock $ 9,100,000     $ 99,999   $ 2,373,561   $ 2,473,560 $ 5,742,171  
Issuance of common shares upon conversion of convertible notes, value                 11,001,274  
Transaction costs       $ 0   $ 0        
Stock compensation expense               2,319,427 $ 2,722,893  
Deemed dividend on warrant modification               $ (450,578)    
Warrants exercised, shares       394,501            
Cashless exercise at fair market value per share       $ 9.00            
Issuance of common shares upon cashless exercise of warrants, shares       315,601            
Stock options outstanding               6,545,628 5,797,185  
Fair value assumptions, contractual term               7 years    
Exercise price percentage               110.00%    
Percentage of shares granted               10.00%    
Warrants exercise price, per share   $ 6.25               $ 6.00
Warrants and rights exercisable period   Jan. 23, 2023                
Class of warrant or right date from which warrants or rights expire   Jul. 27, 2027                
Warrants               $ 245,341    
Gain on remeasurement of warrant liability               $ (98,394) $ 1,546,280  
Warrants issued               115,000    
Principal amount                 $ 8,010,000  
Black-Sholes Method                    
Subsidiary or Equity Method Investee [Line Items]                    
Risk free interest rate 2.82%                  
Volatility rate 77.50%                  
Fair value assumptions, contractual term 5 years                  
Warrants $ 343,735                  
Gain on remeasurement of warrant liability               $ 98,394    
January 1 to January 26, 2022                    
Subsidiary or Equity Method Investee [Line Items]                    
Common stock, par value               $ 8.87    
January 27 to May 31, 2022                    
Subsidiary or Equity Method Investee [Line Items]                    
Sale of common stock, price per share               9    
June 1, 2022 to August 1, 2022                    
Subsidiary or Equity Method Investee [Line Items]                    
Sale of common stock, price per share               $ 5    
January 1, 2021 to February 28, 2021                    
Subsidiary or Equity Method Investee [Line Items]                    
Sale of common stock, price per share                 $ 1.80  
March 1, 2021 to June 6, 2021                    
Subsidiary or Equity Method Investee [Line Items]                    
Sale of common stock, price per share                 $ 1.83  
Maximum                    
Subsidiary or Equity Method Investee [Line Items]                    
Fair value assumptions, contractual term               10 years    
Warrants to purchase common stock   100,000                
General and Administrative Expense                    
Subsidiary or Equity Method Investee [Line Items]                    
Stock compensation expense               $ 1,422,799 $ 1,779,185  
2018 Stock Option Plan                    
Subsidiary or Equity Method Investee [Line Items]                    
Stock options outstanding               1,924,500    
Amended and Restated 2020 Equity Incentive Plan                    
Subsidiary or Equity Method Investee [Line Items]                    
Common stock reserved for issuance               0    
Stock options outstanding               3,983,023    
2021 Equity Incentive Plan                    
Subsidiary or Equity Method Investee [Line Items]                    
Common stock reserved for issuance   1,909,518           1,271,413    
Stock options outstanding               638,105    
IPO                    
Subsidiary or Equity Method Investee [Line Items]                    
Common stock, shares issued   219,872                
Number of common stock sold   2,000,000                
Sale of common stock, price per share   $ 5                
Common stock per share   $ 5.00       $ 5.00        
Gross proceeds from common stock   $ 10,000,000                
Number of warrants exercised   20,520                
Warrants exercise price, per share   $ 5.00                
Overallotment Option                    
Subsidiary or Equity Method Investee [Line Items]                    
Number of common stock sold 300,000                  
Sale of common stock, price per share $ 5                  
Common stock per share $ 5.00                  
Gross proceeds from common stock $ 1,500,000                  
Overallotment Option | Maximum                    
Subsidiary or Equity Method Investee [Line Items]                    
Class of warrant or right additional purchase aggregate of common stock 15,000                  
Common Stock                    
Subsidiary or Equity Method Investee [Line Items]                    
Number of common stock sold       11,111   263,729        
Sale of common stock, price per share       $ 9   $ 9.00        
Issuance of common shares upon conversion of convertible notes, value                 $ 138  
Issuance of common shares upon conversion of convertible notes, Shares                 1,375,228  
Issuance of restricted common shares, Shares                 15,278  
Issuance of common shares upon exercise of warrants, Shares       153,000 61,111     529,712 283,616  
Proceeds from issuance of common stock upon exercise of warrants       $ 275,400 $ 110,000          
Common Stock | IPO                    
Subsidiary or Equity Method Investee [Line Items]                    
Number of common stock sold               2,300,000    
Founder                    
Subsidiary or Equity Method Investee [Line Items]                    
Stock compensation expense                 $ 202,500  
Issuance of restricted common shares, Shares                 87,500  
Restricted Stock Awards                    
Subsidiary or Equity Method Investee [Line Items]                    
Founders shares vested               58,333    
Unvested shares               0 58,333  
Restricted Stock Awards | Founder                    
Subsidiary or Equity Method Investee [Line Items]                    
Shares granted                 112,500  
Unrecognized compensation               $ 52,500    
MAIA Stock Warrants                    
Subsidiary or Equity Method Investee [Line Items]                    
Warrant modification, value         $ 144,497          
Deemed dividend on warrant modification             $ 450,578      
Stock Options                    
Subsidiary or Equity Method Investee [Line Items]                    
Weighted-average grant date fair value               $ 3.75 $ 3.55  
Unrecognized compensation                 $ 3,447,367  
Unrecognized compensation expense, recognized period               3 years 3 months 3 days    
Stock Options | Maximum                    
Subsidiary or Equity Method Investee [Line Items]                    
Fair value assumptions, contractual term               6 years 3 months 6 years 6 months  
Stock Options | Minimum                    
Subsidiary or Equity Method Investee [Line Items]                    
Fair value assumptions, contractual term               5 years 5 years  
T H I O | Founder                    
Subsidiary or Equity Method Investee [Line Items]                    
Issuance of restricted common shares, Shares     612,500              
T H I O | Restricted Stock Awards | Founder                    
Subsidiary or Equity Method Investee [Line Items]                    
Founders shares cancelled     612,500